Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CNAT

Conatus Pharmaceuticals (CNAT) Stock Price, News & Analysis

Conatus Pharmaceuticals logo

About Conatus Pharmaceuticals Stock (NASDAQ:CNAT)

Advanced Chart

Key Stats

Today's Range
$0.0003
$0.0003
50-Day Range
$0.56
$1.34
52-Week Range
$0.23
$1.07
Volume
226 shs
Average Volume
1.28 million shs
Market Capitalization
$9.95 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CNAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Conatus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CNAT Stock News Headlines

See More Headlines

CNAT Stock Analysis - Frequently Asked Questions

Conatus Pharmaceuticals Inc (NASDAQ:CNAT) announced its quarterly earnings results on Friday, May, 1st. The biotechnology company reported ($0.10) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.10). Conatus Pharmaceuticals had a negative trailing twelve-month return on equity of 48.22% and a negative net margin of 52.42%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Conatus Pharmaceuticals investors own include KNOT Offshore Partners (KNOP), Trevena (TRVN), PPL (PPL), (CASC) (CASC), Vaxart (VXRT), Antares Pharma (ATRS) and Dextera Surgical (DXTR).

Company Calendar

Last Earnings
5/01/2020
Today
7/10/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CNAT
CIK
1383701
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.39 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$21.72 million
Price / Cash Flow
N/A
Book Value
$0.53 per share
Price / Book
0.00

Miscellaneous

Free Float
N/A
Market Cap
$9.95 thousand
Optionable
Not Optionable
Beta
1.84
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:CNAT) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners